Company Filing History:
Years Active: 2012
Title: Amy Arlene Weaver: Innovator in Immunology
Introduction
Amy Arlene Weaver is a notable inventor based in North Reading, MA (US). She has made significant contributions to the field of immunology through her innovative research and development of binding proteins. Her work focuses on the human interleukin-21 receptor, which plays a crucial role in immune responses.
Latest Patents
Amy holds 1 patent for her invention titled "Methods of treatment utilizing binding proteins of the interleukin-21 receptor." This patent provides binding proteins and antigen-binding fragments that specifically target the human interleukin-21 receptor (IL-21R). The invention outlines methods for using these binding proteins as antagonists to modulate immune responses, particularly in relation to IL-21R. The applications of her invention include diagnosing, treating, and preventing IL-21R-associated disorders such as inflammatory disorders, autoimmune diseases, allergies, and transplant rejection.
Career Highlights
Amy Arlene Weaver is associated with Wyeth, a company known for its commitment to advancing healthcare through innovative solutions. Her work at Wyeth has allowed her to contribute to groundbreaking research in the field of immunology.
Collaborations
Amy has collaborated with esteemed colleagues, including Laird Bloom and Davinder Gill, to further her research and enhance the impact of her inventions.
Conclusion
Amy Arlene Weaver's contributions to immunology through her innovative patents and collaborations highlight her role as a leading inventor in the field. Her work continues to influence the development of treatments for various immune system disorders.